APO RESEARCH · REPORT
Embolization Particle
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
Product & engineering
Understand the product.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
Selected research
Industry Research
Embolization Particle Industry Research Report 2026
Market perspective
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
Report Scope
Read the full market overview
This report quantifies the global Embolization Particle market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Embolization Particle Market by Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Embolization Particle Segment by Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Embolization Particle Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Embolization Particle Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Embolization Particle by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Embolization Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microspheres
- Particles (e.g. PVA Particles, Gelfoam Particles)
- Drug-eluting Beads (DEBs)
- Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Applications
- Uterine Fibroid Embolization
- Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
- Liver Tumor Embolization
- Trauma Embolization
- Others
Companies covered
- Sirtex Medical
- Merit Medical
- Cook Medical
- BTG Medical
- Boston Scientific Corporation
- Terumo Corporation
- HENGRUI Medical
- INterface BIOmaterials B.V.
- Alicon
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Embolization Particle Market Size (2021-2032)
- 2.2.2 Global Embolization Particle Sales (2021-2032)
- 2.2.3 Global Embolization Particle Market Average Price (2021-2032)
- 2.3 Embolization Particle by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Microspheres
- 2.3.3 Particles (e.g. PVA Particles, Gelfoam Particles)
- 2.3.4 Drug-eluting Beads (DEBs)
- 2.3.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
- 2.4 Embolization Particle by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Uterine Fibroid Embolization
- 2.4.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
- 2.4.4 Liver Tumor Embolization
- 2.4.5 Trauma Embolization
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Embolization Particle Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Embolization Particle Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Embolization Particle Revenue of Manufacturers (2021-2026)
- 3.4 Global Embolization Particle Average Price by Manufacturers (2021-2026)
- 3.5 Global Embolization Particle Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Embolization Particle, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Embolization Particle, Product Type & Application
- 3.8 Global Manufacturers of Embolization Particle, Established Date
- 3.9 Global Embolization Particle Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sirtex Medical
- 4.1.1 Sirtex Medical Company Information
- 4.1.2 Sirtex Medical Business Overview
- 4.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sirtex Medical Embolization Particle Product Portfolio
- 4.1.5 Sirtex Medical Recent Developments
- 4.2 Merit Medical
- 4.2.1 Merit Medical Company Information
- 4.2.2 Merit Medical Business Overview
- 4.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merit Medical Embolization Particle Product Portfolio
- 4.2.5 Merit Medical Recent Developments
- 4.3 Cook Medical
- 4.3.1 Cook Medical Company Information
- 4.3.2 Cook Medical Business Overview
- 4.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cook Medical Embolization Particle Product Portfolio
- 4.3.5 Cook Medical Recent Developments
- 4.4 BTG Medical
- 4.4.1 BTG Medical Company Information
- 4.4.2 BTG Medical Business Overview
- 4.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BTG Medical Embolization Particle Product Portfolio
- 4.4.5 BTG Medical Recent Developments
- 4.5 Boston Scientific Corporation
- 4.5.1 Boston Scientific Corporation Company Information
- 4.5.2 Boston Scientific Corporation Business Overview
- 4.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
- 4.5.5 Boston Scientific Corporation Recent Developments
- 4.6 Terumo Corporation
- 4.6.1 Terumo Corporation Company Information
- 4.6.2 Terumo Corporation Business Overview
- 4.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Terumo Corporation Embolization Particle Product Portfolio
- 4.6.5 Terumo Corporation Recent Developments
- 4.7 HENGRUI Medical
- 4.7.1 HENGRUI Medical Company Information
- 4.7.2 HENGRUI Medical Business Overview
- 4.7.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 HENGRUI Medical Embolization Particle Product Portfolio
- 4.7.5 HENGRUI Medical Recent Developments
- 4.8 INterface BIOmaterials B.V.
- 4.8.1 INterface BIOmaterials B.V. Company Information
- 4.8.2 INterface BIOmaterials B.V. Business Overview
- 4.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
- 4.8.5 INterface BIOmaterials B.V. Recent Developments
- 4.9 Alicon
- 4.9.1 Alicon Company Information
- 4.9.2 Alicon Business Overview
- 4.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Alicon Embolization Particle Product Portfolio
- 4.9.5 Alicon Recent Developments
5 Global Embolization Particle Market Scenario by Region
- 5.1 Global Embolization Particle Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Embolization Particle Sales by Region: 2021-2032
- 5.2.1 Global Embolization Particle Sales by Region: 2021-2026
- 5.2.2 Global Embolization Particle Sales by Region: 2027-2032
- 5.3 Global Embolization Particle Revenue by Region: 2021-2032
- 5.3.1 Global Embolization Particle Revenue by Region: 2021-2026
- 5.3.2 Global Embolization Particle Revenue by Region: 2027-2032
- 5.4 North America Embolization Particle Market Facts & Figures by Country
- 5.4.1 North America Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Embolization Particle Sales by Country (2021-2032)
- 5.4.3 North America Embolization Particle Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Embolization Particle Market Facts & Figures by Country
- 5.5.1 Europe Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Embolization Particle Sales by Country (2021-2032)
- 5.5.3 Europe Embolization Particle Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Embolization Particle Market Facts & Figures by Country
- 5.6.1 Asia Pacific Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Embolization Particle Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Embolization Particle Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Embolization Particle Market Facts & Figures by Country
- 5.7.1 South America Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Embolization Particle Sales by Country (2021-2032)
- 5.7.3 South America Embolization Particle Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Embolization Particle Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Embolization Particle Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Embolization Particle Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Embolization Particle Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Embolization Particle Sales by Type (2021-2032)
- 6.1.1 Global Embolization Particle Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Embolization Particle Sales Market Share by Type (2021-2032)
- 6.2 Global Embolization Particle Revenue by Type (2021-2032)
- 6.2.1 Global Embolization Particle Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Embolization Particle Revenue Market Share by Type (2021-2032)
- 6.3 Global Embolization Particle Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Embolization Particle Sales by Application (2021-2032)
- 7.1.1 Global Embolization Particle Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Embolization Particle Sales Market Share by Application (2021-2032)
- 7.2 Global Embolization Particle Revenue by Application (2021-2032)
- 7.2.1 Global Embolization Particle Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Embolization Particle Revenue Market Share by Application (2021-2032)
- 7.3 Global Embolization Particle Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Embolization Particle Value Chain Analysis
- 8.1.1 Embolization Particle Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Embolization Particle Production Mode & Process
- 8.2 Embolization Particle Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Embolization Particle Distributors
- 8.2.3 Embolization Particle Customers
9 Global Embolization Particle Analyzing Market Dynamics
- 9.1 Embolization Particle Industry Trends
- 9.2 Embolization Particle Industry Drivers
- 9.3 Embolization Particle Industry Opportunities and Challenges
- 9.4 Embolization Particle Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst